Outset Medical, Inc. Unrecognized Tax Benefits, Increase Resulting from Current Period Tax Positions
Outset Medical, Inc. (OM) reported Unrecognized Tax Benefits, Increase Resulting from Current Period Tax Positions of $548.00 thousand for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-13.
Financial Statements › Notes › Income Taxes › Income Tax Uncertainties
us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions · last filed 2026-02-13
- Outset Medical, Inc. unrecognized tax benefits, increase resulting from current period tax positions for fiscal 2025 was $548.00K, a 14.64% decline from fiscal 2024.
- Outset Medical, Inc. unrecognized tax benefits, increase resulting from current period tax positions for fiscal 2024 was $642.00K, a 14.85% decline from fiscal 2023.
- Outset Medical, Inc. unrecognized tax benefits, increase resulting from current period tax positions for fiscal 2023 was $754.00K, a 5.75% decline from fiscal 2022.
- Outset Medical, Inc. unrecognized tax benefits, increase resulting from current period tax positions for fiscal 2022 was $800.00K, a 31.58% increase from fiscal 2021.
| Period end | Unrecognized Tax Benefits, Increase Resulting from Current Period Tax Positions 12 month |
|---|---|
| 2025-12-31 | $548.00K 10-K · filed 2026-02-13 |
| 2024-12-31 | $642.00K 10-K · filed 2026-02-13 |
| 2023-12-31 | $754.00K 10-K · filed 2025-02-28 |
| 2022-12-31 | $800.00K 10-K · filed 2024-02-21 |
| 2021-12-31 | $608.00K 10-K · filed 2023-02-13 |
| 2020-12-31 | $562.00K 10-K · filed 2022-02-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PRECISION OPTICS CORPORATION, INC. (POCI) | United States | $0.052B | |
| QT IMAGING HOLDINGS, INC. (QTI) | United States | $0.037B | |
| Streamex Corp. (STEX) | United States | $0.089B | -0.19 |
| Nexalin Technology, Inc. (NXL) | United States | $0.094B | |
| Neuraxis, INC (NRXS) | United States | $0.097B | |
| electroCore, Inc. (ECOR) | United States | $0.102B | |
| IRIDEX CORP (IRIX) | United States | $0.011B | |
| ENDRA Life Sciences Inc. (NDRA) | United States | $0.009B | |
| Vivani Medical, Inc. (VANI) | United States | $0.111B | |
| Nuwellis, Inc. (NUWE) | United States | $0.003B |